Generic placeholder image

Inflammation & Allergy - Drug Targets (Discontinued)

Editor-in-Chief

ISSN (Print): 1871-5281
ISSN (Online): 2212-4055

Immunological Mechanisms of Specific Allergen Immunotherapy

Author(s): Carsten B. Schmidt-Weber and Kurt Blaser

Volume 5, Issue 1, 2006

Page: [15 - 21] Pages: 7

DOI: 10.2174/187152806775269321

Price: $65

Abstract

Allergy is an immunological disorder, which is driven by uncontrolled allergen-activated T cell subsets, leading to immediate type hypersensitivity against otherwise harmless environmental allergens. These allergens are tolerated by healthy individuals as well as by patients, who successfully underwent allergen-specific immunotherapy (SIT). The successful SIT is characterized by the induction of T cell unresponsiveness against the given allergen. Regulatory T cells (Tregs), which are installed or enhanced by SIT and govern the activity of potentially pro-allergic effector T cells, mediate this unresponsiveness. The current article reviews the mechanisms underlying the balance of these cell populations along with suppressive mechanisms of SIT, which may serve as future drug targets.

Keywords: inflammatory factors, allergy, antigen-presenting cells, pathogen-associated molecular patterns (PAMPs), phosphatidylinositol, , 3-phosphatase (PI3K)


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy